Compounding Pharmacies Market: Industry Analysis, Trend, Growth, Opportunity, Forecast 2022-2030

in #compounding3 years ago

Global Market Insights recently introduced report on Global Compounding Pharmacies Market Report is an in-depth study providing complete analysis of the industry for the period 2022 to 2030. It provides complete overview of Global Compounding Pharmacies industry considering all the major industry trends, market dynamics and competitive scenario.

The compounding pharmacies market is speculated to grow massively by 2030 owing to widespread adoption of customized medicine in developed regions. In addition, expanding geriatric population, along with a shortage of drugs, is likely to further propel market growth through the forecast period.

Browse key industry insights spread across 530 pages with 939 market data tables & 24 figures & charts from the report, “Compounding Pharmacies Market Analysis, By Therapeutic Area (Nutritional Supplements, Hormone Replacement, Dermatology, Pain Management, Specialty Drugs), By Product (Liquid Preparations [Solutions, Emulsion, Suspension, Syrup], Oral {Solid Preparations [Tablets, Granules, Capsules, Powder]}, Topical {Ointments, Gels, Creams, Pastes}, Parenteral {LVP, SVP}, Rectal {Enema, Suppositories }, Nasal, Otic, Ophthalmic,), By Application (Pediatric, Geriatric, Adult, Veterinary), By Compounding Type (Pharmaceutical Dosage Alteration [PDA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Ingredient Alteration [PIA]), By Sterility (Non-sterile, Sterile), By Distribution Channel (Compounding Pharmacy, Hospital Pharmacy) Regional Outlook, Covid-19 Impact Analysis, Industry Analysis Report, Price Trends, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/compounding-pharmacies-market

The emergence of the COVID-19 pandemic provided the industry with new opportunities to prosper in recent years. Increasing demand for medications from hospital and compounding pharmacies to curb the spread of the coronavirus infection escalated the utilization of compounded drugs. Furthermore, government authorization to maintain the availability of these drugs aided market expansion.

Moreover, key players in the market have been engaging in rigorous R&D and strategic acquisitions and collaborations to expand their customer base and improve their industry standing. For instance, in March 2022, B. Braun, a German medical and pharmaceutical company, acquired Intermedt Medizin & Technik GmbH, an expert in the preparation of dialysis concentrates. The acquisition was intended to aid the company in expanding its business in the field of dialysis concentrates.

The compounding pharmacies market has been bifurcated in terms of product, therapeutic area, application, sterility, compounding type, distribution channel, and region.

With respect to therapeutic area, the industry has been divided into nutritional supplements, hormone replacement, dermatology, pain management, specialty drugs, and others. The dermatology segment is expected to grow at approximately 6.4% CAGR over the analysis timeframe. Growing skin-related concerns viz., skin aging and sunburns, coupled with soaring need for healthy skin, are major factors that are poised to drive the demand for compounding medicines for dermatological usage. Additionally, the ability of compounded dermatological drugs to accommodate individual needs and overcome issues related to allergies and sensitivities caused by commercially available skin care medications is set to boost segmental progress.

The compounding pharmacies market has been classified based on product into oral, topical, parenteral, rectal, nasal, otic, and ophthalmic. The topical segment size was registered at over $1,727.2 million in 2021 and is slated to attain substantial gains by 2030. The growth is attributed to ease of drug delivery, drug formulations, and rising demand for ointments, gels, creams, patches, lotions, and sprays, especially for pain management owing to their faster action at the site of application. Moreover, prominent R&D activities for the development of innovative topical medications using compounding pharmacies to cater to specific patient requirements are also projected to propel segmental expansion.

From application point of reference, the compounding pharmacies market has been segregated into pediatric, geriatric, adult, and veterinary. In 2021, the pediatric segment accounted for above $1,653.2 million valuation and is estimated to record significant expansion in the coming years. Several benefits of compounded medications, such as dose alteration, ingredient alteration, and the advantage of altering the route of administration, are likely to increase the demand for compounded medications for pediatric usage.

Partial Table of Contents (ToC) of the report:
Chapter 4 Compounding Pharmacies Market, By Therapeutic Area
4.1 Key segment trends
4.2 Hormone replacement
4.2.1 Market size, by region, 2017-2030 (USD Million)
4.3 Pain management
4.3.1 Market size, by region, 2017-2030 (USD Million)
4.4 Dermatology applications
4.4.1 Market size, by region, 2017-2030 (USD Million)
4.5 Specialty drugs
4.5.1 Market size, by region, 2017-2030 (USD Million)
4.6 Nutritional supplements
4.6.1 Market size, by region, 2017-2030 (USD Million)
4.7 Others
4.7.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Compounding Pharmacies Market, By Product
5.1 Key segment trends
5.2 Oral
5.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.2 Solid preparations
5.2.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.2 Tablets
5.2.2.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.3 Capsules
5.2.2.3.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.4 Granules
5.2.2.4.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.5 Powder
5.2.2.5.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.6 Others
5.2.2.6.1 Market size, by region, 2017-2030 (USD Million)
5.2.3 Liquid preparations
5.2.3.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.2 Solution
5.2.3.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.3 Suspension
5.2.3.3.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.4 Emulsion
5.2.3.4.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.5 Syrup
5.2.3.5.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.6 Others
5.2.3.6.1 Market size, by region, 2017-2030 (USD Million)
5.3 Topical
5.3.1 Market size, by region, 2017-2030 (USD Million)
5.3.2 Ointments
5.3.2.1 Market size, by region, 2017-2030 (USD Million)
5.3.3 Creams
5.3.3.1 Market size, by region, 2017-2030 (USD Million)
5.3.4 Gels
5.3.4.1 Market size, by region, 2017-2030 (USD Million)
5.3.5 Pastes
5.3.5.1 Market size, by region, 2017-2030 (USD Million)
5.3.6 Others
5.3.6.1 Market size, by region, 2017-2030 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/compounding-pharmacies-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: +1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email: [email protected]